MPR Weekly Dose 140 — COVID-19 Vaccines; Narcan for OTC; Diabetes Tx in Peds; Major Depressive Disorder Therapy Fast Tracked; Tecentriq Indication Withdrawn

<p><span style="font-weight: 400;">New authorization for COVID-19 vaccines in certain children; Narcan nasal spray to be reviewed for OTC status; Empagliflozin assessed in children with diabetes; a major depressive disorder therapy gains fast track status; and Tecentriq has an indication withdrawn. </span></p>